To access this element change to forms mode OFF
Grant Award View - GA386206
Unlocking the potential of the blood-brain barrier in the fight against...
GA ID:
GA386206
Agency:
Cancer Australia
Approval Date:
26-Jun-2024
Publish Date:
2-Jul-2024
Category:
Cancer
Grant Term:
30-Jun-2024 to 30-Jun-2027
Value (AUD):
$586,674.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
CA 23/24 CA
Grant Program:
2023 Priority-driven Collaborative Cancer Research scheme
Grant Activity:
Unlocking the potential of the blood-brain barrier in the fight against paediatric brain gliomas
Purpose:
Diffuse Midline Glioma (DMG) is a deadly childhood brain cancer. Treatment is limited as it is difficult to deliver therapies across the blood-brain barrier (BBB). DMGs impact specific pathways in endothelial cells that maintain the integrity of the BBB. By modifying BBB integrity with clinically available drugs, this project aims to improve penetration of the BBB by treatments.
GO ID:
GO Title:
2023 Priority-driven Collaborative Cancer Research Scheme for funding commencing in 2024
InternalReferenceId:
2023/PCRS/0185_Ziegler
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Kensington
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
2052
Country:
AUSTRALIA